107 related articles for article (PubMed ID: 35131482)
1. CX-5461 is a potent immunosuppressant which inhibits T cell-mediated alloimmunity via p53-DUSP5.
Pan G; Zhang J; Han Y; Chen Y; Guo X; Cui X; Cheng M; Gao H; Wang J; Jiang F
Pharmacol Res; 2022 Mar; 177():106120. PubMed ID: 35131482
[TBL] [Abstract][Full Text] [Related]
2. The Selective RNA Polymerase I Inhibitor CX-5461 Mitigates Neointimal Remodeling in a Modified Model of Rat Aortic Transplantation.
Dai C; Sun M; Wang F; Zhu J; Wei Y; Guo X; Ma S; Dong B; Wang G; Jiang F; Wang J
Transplantation; 2018 Oct; 102(10):1674-1683. PubMed ID: 30247451
[TBL] [Abstract][Full Text] [Related]
3. Boosting regulatory T cell-dependent immune tolerance by activation of p53.
Cui X; Li CG; Gao H; Cheng M; Jiang F
Int Immunopharmacol; 2023 Dec; 125(Pt A):111167. PubMed ID: 37931392
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targeting of RNA Polymerase I With the Small-Molecule CX-5461 for Prevention of Arterial Injury-Induced Neointimal Hyperplasia.
Ye Q; Pang S; Zhang W; Guo X; Wang J; Zhang Y; Liu Y; Wu X; Jiang F
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):476-484. PubMed ID: 28062495
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling.
Quin J; Chan KT; Devlin JR; Cameron DP; Diesch J; Cullinane C; Ahern J; Khot A; Hein N; George AJ; Hannan KM; Poortinga G; Sheppard KE; Khanna KK; Johnstone RW; Drygin D; McArthur GA; Pearson RB; Sanij E; Hannan RD
Oncotarget; 2016 Aug; 7(31):49800-49818. PubMed ID: 27391441
[TBL] [Abstract][Full Text] [Related]
6. Dual Specificity Phosphatase 5 Is Essential for T Cell Survival.
Kutty RG; Xin G; Schauder DM; Cossette SM; Bordas M; Cui W; Ramchandran R
PLoS One; 2016; 11(12):e0167246. PubMed ID: 27936095
[TBL] [Abstract][Full Text] [Related]
7. MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer.
Bian Y; Han J; Kannabiran V; Mohan S; Cheng H; Friedman J; Zhang L; VanWaes C; Chen Z
Int J Biol Sci; 2015; 11(4):411-22. PubMed ID: 25798061
[TBL] [Abstract][Full Text] [Related]
8. Shikonin Prolongs Allograft Survival via Induction of CD4
Zeng Q; Qiu F; Chen Y; Liu C; Liu H; Liang CL; Zhang Q; Dai Z
Front Immunol; 2019; 10():652. PubMed ID: 30988670
[TBL] [Abstract][Full Text] [Related]
9. NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats.
Shibasaki S; Yamashita K; Goto R; Oura T; Wakayama K; Hirokata G; Shibata T; Igarashi R; Haga S; Ozaki M; Todo S
Transpl Immunol; 2012 Jan; 26(1):42-9. PubMed ID: 22019622
[TBL] [Abstract][Full Text] [Related]
10. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
Ferguson BS; Harrison BC; Jeong MY; Reid BG; Wempe MF; Wagner FF; Holson EB; McKinsey TA
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9806-11. PubMed ID: 23720316
[TBL] [Abstract][Full Text] [Related]
11. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
12. Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53.
Ueda K; Arakawa H; Nakamura Y
Oncogene; 2003 Aug; 22(36):5586-91. PubMed ID: 12944906
[TBL] [Abstract][Full Text] [Related]
13. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
Drygin D; Lin A; Bliesath J; Ho CB; O'Brien SE; Proffitt C; Omori M; Haddach M; Schwaebe MK; Siddiqui-Jain A; Streiner N; Quin JE; Sanij E; Bywater MJ; Hannan RD; Ryckman D; Anderes K; Rice WG
Cancer Res; 2011 Feb; 71(4):1418-30. PubMed ID: 21159662
[TBL] [Abstract][Full Text] [Related]
14. T-cell development and function are modulated by dual specificity phosphatase DUSP5.
Kovanen PE; Bernard J; Al-Shami A; Liu C; Bollenbacher-Reilley J; Young L; Pise-Masison C; Spolski R; Leonard WJ
J Biol Chem; 2008 Jun; 283(25):17362-9. PubMed ID: 18430737
[TBL] [Abstract][Full Text] [Related]
15. Dual-specificity phosphatase 5 acts as an anti-inflammatory regulator by inhibiting the ERK and NF-κB signaling pathways.
Seo H; Cho YC; Ju A; Lee S; Park BC; Park SG; Kim JH; Kim K; Cho S
Sci Rep; 2017 Dec; 7(1):17348. PubMed ID: 29229953
[TBL] [Abstract][Full Text] [Related]
16. CX-659S, a diaminouracil derivative, indirectly inhibits the function of Langerhans cells by blocking the MEK1/2-Erk1/2 pathway in keratinocytes.
Uchi H; Koga T; Urabe K; Moroi Y; Furue M
J Invest Dermatol; 2003 Jun; 120(6):983-9. PubMed ID: 12787125
[TBL] [Abstract][Full Text] [Related]
17. Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expression.
Rushworth LK; Kidger AM; Delavaine L; Stewart G; van Schelven S; Davidson J; Bryant CJ; Caddye E; East P; Caunt CJ; Keyse SM
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18267-72. PubMed ID: 25489104
[TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.
Haskell CA; Hancock WW; Salant DJ; Gao W; Csizmadia V; Peters W; Faia K; Fituri O; Rottman JB; Charo IF
J Clin Invest; 2001 Sep; 108(5):679-88. PubMed ID: 11544273
[TBL] [Abstract][Full Text] [Related]
19. DUSP5 (dual-specificity protein phosphatase 5) suppresses BCG-induced autophagy via ERK 1/2 signaling pathway.
Luo J; Xue D; Song F; Liu X; Li W; Wang Y
Mol Immunol; 2020 Oct; 126():101-109. PubMed ID: 32795663
[TBL] [Abstract][Full Text] [Related]
20. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
